Skip to Main Content
 

Global Search Box

 
 
 
 

Files

File List


Final Dissertation Rose Yaghi.pdf (2.16 MB)

ETD Abstract Container

Abstract Header

Strategizing A Vibrant and Competitive Market Integration of Biosimilars: A Health Care Provider Clinical Adoption Plan.

Yaghi, Rose
http://rave.ohiolink.edu/etdc/view?acc_num=frank1717614915635326

Abstract Details

2024, Doctor of Healthcare Administration (D.H.A.), Franklin University, Health Programs.
As of the end of the twentieth century, biological drug therapies were at the forefront of health research for treating life-threatening diseases. Despite their therapeutical benefits stemming from providing great treatment hope against lethal diseases, biological drugs end up placing a financial burden on the American healthcare system. In the last decade, biological drug skyrocketing prices have significantly impacted net drug expenditures. The biological drug market needs more competitors. This impacted the passage of the Biological Price Competition and Innovation Act in 2010, introducing biosimilars, the highly safe and effective but less expensive biological copycat alternative drugs. However, a decade after biosimilars introduction, healthcare administration barriers limit American pharmacists and physicians from adopting biosimilars. Hence, the current low American health care provider biosimilar adoption rate must be improved to realize significant healthcare savings. Although many literature studies have examined biosimilar clinical adoption hurdles among American pharmacists and physicians in their siloed medical care settings, they have yet to focus on creating a comprehensive un-siloed biosimilar adoption plan based on their inputs. Therefore, to determine the essential elements to boost biosimilar adoption, this qualitative exploratory study thoroughly examined the literature. It then gathered the viewpoints of pharmacists and physicians who were acquainted with biosimilars by conducting semi-structured question interviews with 13 pharmacists and 8 physicians for a total of 21 participants. The findings of this study suggest that to create a dynamic and competitive biosimilar comprehensive clinical adoption plan, increasing HCPP education, having sufficient healthcare reimbursement, improving the roles of essential stakeholders, and increasing communication among key stakeholders are all necessary to increase biosimilars' trust and adoption, facilitating the U.S. healthcare system transition to a value-based care model.
David Meckstroth (Committee Chair)
Karen Lankisch (Committee Member)
Bora Pajo (Committee Member)
275 p.
Health; Health Care; Health Care Management; Health Education; Health Sciences; Higher Education; Higher Education Administration
Biosimilars; biologics; health care providers; clinical adoption plan; pharmacists; physicians; dynamic market integration; shared-decision making; market competition; skyrocketing medication prices; qualitative study

Recommended Citations

Citations

  • Yaghi, R. (2024). Strategizing A Vibrant and Competitive Market Integration of Biosimilars: A Health Care Provider Clinical Adoption Plan. [Doctoral dissertation, Franklin University]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=frank1717614915635326

    APA Style (7th edition)

  • Yaghi, Rose. Strategizing A Vibrant and Competitive Market Integration of Biosimilars: A Health Care Provider Clinical Adoption Plan. 2024. Franklin University, Doctoral dissertation. OhioLINK Electronic Theses and Dissertations Center, http://rave.ohiolink.edu/etdc/view?acc_num=frank1717614915635326.

    MLA Style (8th edition)

  • Yaghi, Rose. "Strategizing A Vibrant and Competitive Market Integration of Biosimilars: A Health Care Provider Clinical Adoption Plan." Doctoral dissertation, Franklin University, 2024. http://rave.ohiolink.edu/etdc/view?acc_num=frank1717614915635326

    Chicago Manual of Style (17th edition)

frank1717614915635326
137
© 2024, all rights reserved.
This open access ETD is published by Franklin University and OhioLINK.